09.07.2024 13:40:55 - dpa-AFX: *PRELUDE ANNOUNCES CLINICAL COLLABORATION WITH MERCK TO EVALUATE PRT3789 WITH KEYTRUDA IN SMARCA4-MUTATED CANCERS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
MERCK CO. DL-,01 A0YD8Q Frankfurt 104,400 31.07.24 18:41:38 -3,000 -2,79% 104,600 104,800 106,800 107,400

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH